Adaptimmune Therapeutics plc (ADAP)

Adaptimmune Therapeutics Statistics

Total Valuation

ADAP has a market cap or net worth of $154.78 million. The enterprise value is $43.19 million.

Market Cap	154.78M
Enterprise Value	43.19M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

ADAP has 255.88 million shares outstanding. The number of shares has increased by 32.34% in one year.

Current Share Class	n/a
Shares Outstanding	255.88M
Shares Change (YoY)	+32.34%
Shares Change (QoQ)	-1.58%
Owned by Insiders (%)	0.68%
Owned by Institutions (%)	22.48%
Float	173.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.85
Forward PS	4.92
PB Ratio	1.93
P/TBV Ratio	2.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.85, with a Debt / Equity ratio of 0.93.

Current Ratio	3.85
Quick Ratio	3.54
Debt / Equity	0.93
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-23.09

Financial Efficiency

Return on equity (ROE) is -52.96% and return on invested capital (ROIC) is -17.59%.

Return on Equity (ROE)	-52.96%
Return on Assets (ROA)	-7.68%
Return on Capital (ROIC)	-17.59%
Revenue Per Employee	$389,846
Profits Per Employee	-$99,145
Employee Count	449
Asset Turnover	0.57
Inventory Turnover	87.81

Taxes

In the past 12 months, ADAP has paid $1.23 million in taxes.

Income Tax	1.23M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.50% in the last 52 weeks. The beta is 2.18, so ADAP's price volatility has been higher than the market average.

Beta (5Y)	2.18
52-Week Price Change	+31.50%
50-Day Moving Average	0.72
200-Day Moving Average	1.04
Relative Strength Index (RSI)	38.32
Average Volume (20 Days)	2,220,892

Short Selling Information

Short Interest	6.72M
Short Previous Month	6.91M
Short % of Shares Out	3.14%
Short % of Float	n/a
Short Ratio (days to cover)	4.71

Income Statement

In the last 12 months, ADAP had revenue of $175.04 million and -$44.52 million in losses. Loss per share was -$0.18.

Revenue	175.04M
Gross Profit	31.87M
Operating Income	-37.75M
Pretax Income	-162.17M
Net Income	-44.52M
EBITDA	-26.49M
EBIT	-37.75M
Loss Per Share	-$0.18

Balance Sheet

The company has $186.09 million in cash and $74.50 million in debt, giving a net cash position of $111.60 million or $0.44 per share.

Cash & Cash Equivalents	186.09M
Total Debt	74.50M
Net Cash	111.60M
Net Cash Per Share	$0.44
Equity (Book Value)	79.99M
Book Value Per Share	0.31
Working Capital	180.76M

Cash Flow

In the last 12 months, operating cash flow was -$53.68 million and capital expenditures -$1.49 million, giving a free cash flow of -$55.17 million.

Operating Cash Flow	-53.68M
Capital Expenditures	-1.49M
Free Cash Flow	-55.17M
FCF Per Share	-$0.22

Margins

Gross margin is 18.21%, with operating and profit margins of -21.57% and -25.43%.

Gross Margin	18.21%
Operating Margin	-21.57%
Pretax Margin	-24.73%
Profit Margin	-25.43%
EBITDA Margin	-15.13%
EBIT Margin	-21.57%
FCF Margin	n/a

Dividends & Yields

ADAP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.34%
Shareholder Yield	-32.34%
Earnings Yield	-28.76%
FCF Yield	-35.64%

Analyst Forecast

The average price target for ADAP is $2.79, which is 361.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.79
Price Target Difference	361.23%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	31.28%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ADAP has an Altman Z-Score of -3.04 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.04
Piotroski F-Score	3